127 related articles for article (PubMed ID: 2108114)
21. Mechanism for synergism between sulphonamides and trimethoprim clarified.
Richards RM; Taylor RB; Zhu ZY
J Pharm Pharmacol; 1996 Sep; 48(9):981-4. PubMed ID: 8910868
[TBL] [Abstract][Full Text] [Related]
22. Promoter strength of folic acid synthesis genes affects sulfa drug resistance in Saccharomyces cerevisiae.
Iliades P; Berglez J; Meshnick S; Macreadie I
Microb Drug Resist; 2003; 9(3):249-55. PubMed ID: 12959403
[TBL] [Abstract][Full Text] [Related]
23. Wet disc testing of mafenide hydrochloride, chlorhexidine gluconate, and triple antibiotic solution against bacteria isolated from burn wounds.
Holder IA
J Burn Care Rehabil; 1990; 11(4):301-4. PubMed ID: 2401684
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of dihydropteroate synthetase from Escherichia coli by sulfones and sulfonamides.
McCullough JL; Maren TH
Antimicrob Agents Chemother; 1973 Jun; 3(6):665-9. PubMed ID: 4597736
[TBL] [Abstract][Full Text] [Related]
25. 8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.
Dennis ML; Lee MD; Harjani JR; Ahmed M; DeBono AJ; Pitcher NP; Wang ZC; Chhabra S; Barlow N; Rahmani R; Cleary B; Dolezal O; Hattarki M; Aurelio L; Shonberg J; Graham B; Peat TS; Baell JB; Swarbrick JD
Chemistry; 2018 Feb; 24(8):1922-1930. PubMed ID: 29171692
[TBL] [Abstract][Full Text] [Related]
26. Quantitative structure-activity relationships in dihydropteroate synthase inhibition by multisubstituted sulfones. Design and synthesis of some new derivatives with improved potency.
De Benedetti PG; Iarossi D; Folli U; Frassineti C; Menziani MC; Cennamo C
J Med Chem; 1989 Oct; 32(10):2396-9. PubMed ID: 2677378
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs.
Zhang Y; Meshnick SR
Antimicrob Agents Chemother; 1991 Feb; 35(2):267-71. PubMed ID: 2024960
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase.
Achari A; Somers DO; Champness JN; Bryant PK; Rosemond J; Stammers DK
Nat Struct Biol; 1997 Jun; 4(6):490-7. PubMed ID: 9187658
[TBL] [Abstract][Full Text] [Related]
30. Toxoplasma gondii: characterization of a mutant resistant to sulfonamides.
Pfefferkorn ER; Borotz SE; Nothnagel RF
Exp Parasitol; 1992 May; 74(3):261-70. PubMed ID: 1582478
[TBL] [Abstract][Full Text] [Related]
31. Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitors.
Das BK; Pv P; Chakraborty D
Comput Biol Chem; 2019 Feb; 78():37-52. PubMed ID: 30497019
[TBL] [Abstract][Full Text] [Related]
32. Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model.
Iliades P; Meshnick SR; Macreadie IG
Antimicrob Agents Chemother; 2004 Jul; 48(7):2617-23. PubMed ID: 15215118
[TBL] [Abstract][Full Text] [Related]
33. Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium.
Chio LC; Bolyard LA; Nasr M; Queener SF
Antimicrob Agents Chemother; 1996 Mar; 40(3):727-33. PubMed ID: 8851601
[TBL] [Abstract][Full Text] [Related]
34. Mafenide (Sulfamylon) inhibits plasmin fibrinolytic activity.
Weisdorf DJ; Aldridge JH
Thromb Haemost; 1988 Jun; 59(3):440-4. PubMed ID: 2973151
[TBL] [Abstract][Full Text] [Related]
35. The characteristics and significance of sulfonamides as substrates for Escherichia coli dihydropteroate synthase.
Roland S; Ferone R; Harvey RJ; Styles VL; Morrison RW
J Biol Chem; 1979 Oct; 254(20):10337-45. PubMed ID: 385600
[No Abstract] [Full Text] [Related]
36. Arabidopsis dihydropteroate synthase: general properties and inhibition by reaction product and sulfonamides.
Prabhu V; Lui H; King J
Phytochemistry; 1997 May; 45(1):23-7. PubMed ID: 9127492
[TBL] [Abstract][Full Text] [Related]
37. Dihydropteroate synthase from Streptococcus pneumoniae: structure, ligand recognition and mechanism of sulfonamide resistance.
Levy C; Minnis D; Derrick JP
Biochem J; 2008 Jun; 412(2):379-88. PubMed ID: 18321242
[TBL] [Abstract][Full Text] [Related]
38. Cell-free dihydropteroate synthetase activity: its use to investigate the relationship between structure and activity of p-aminobenzoic derivatives.
Thijssen HH
Methods Enzymol; 1980; 66():570-6. PubMed ID: 6990197
[No Abstract] [Full Text] [Related]
39. Evaluation of sulfa drugs against recombinant Pneumocystis carinii dihydropteroate synthetase and in vivo.
Hong YL; Hossler P; Bartlett M; Queener S; Smith J; Meshnick S
J Eukaryot Microbiol; 1996; 43(5):40S. PubMed ID: 8822843
[No Abstract] [Full Text] [Related]
40. Sulfonamide resistance mechanism in Escherichia coli: R plasmids can determine sulfonamide-resistant dihydropteroate synthases.
Wise EM; Abou-Donia MM
Proc Natl Acad Sci U S A; 1975 Jul; 72(7):2621-5. PubMed ID: 1101260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]